Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

CAPRICOR THERAPEUTICS, INC. Director's Dealing 2021

Jul 28, 2021

33192_dirs_2021-07-27_ece239d9-b390-43cf-95db-08054a36b0d4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: CAPRICOR THERAPEUTICS, INC. (CAPR)
CIK: 0001133869
Period of Report: 2021-07-23

Reporting Person: Sabar Karimah Es (Director)

More from CAPRICOR THERAPEUTICS, INC.

Interim / Quarterly Report 2026
May 13
Annual Report 2026
Apr 10
Proxy Solicitation & Information Statement 2026
Apr 10
Director's Dealing 2026
Mar 28
Share Issue/Capital Change 2026
Jan 30
Major Shareholding Notification 2026
Jan 26
Director's Dealing 2026
Jan 7
Director's Dealing 2026
Jan 7
Director's Dealing 2026
Jan 7
Director's Dealing 2026
Jan 7
View all filings →